Background We sought to identify an optimal oral corticosteroid regimen at the onset of myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), which would delay time to first relapse ...

The objective of this paper is to evaluate available evidence for each step in autoimmune encephalitis management and provide expert opinion when evidence is lacking. The paper approaches autoimmune ...

During a live event, Hannah Choe, MD, and event participants discuss steroid-dependent chronic GVHD, favoring adding therapy over increasing steroids. Chronic graft-vs-host disease (GVHD) is a cause ...

Correspondence to Dr Duvuru Geetha, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA; dgeetha1{at}jhmi.edu Objectives To evaluate the efficacy and safety ...

When added to standard care, more lupus nephritis patients achieved complete remissions with obinutuzumab (Gazyva) than with placebo. Treatment was added to mycophenolate mofetil and glucocorticoids.

Initiating glucocorticoids within 7 days of symptom-onset was associated with reduced relapse risk and lower prednisone doses during tapering among patients with giant cell arteritis. Initiating ...

Miriam Freimer, MD, clinical professor of neurology at The Ohio State University Wexner Medical Center, reflects on how findings from the RAISE-XT trial potentially translate to real-world practice ...

Avacopan was safe and effective among patients with respiratory tract manifestations of antineutrophil cytoplasmic antibody-associated vasculitis. Avacopan shows promising efficacy and safety among ...

Avacopan was safe and effective among patients with respiratory tract manifestations of antineutrophil cytoplasmic antibody-associated vasculitis. Researchers performed a post hoc analysis of the ...

A panelist discusses how identifying steroid-dependent or steroid-refractory (SR) graft-vs-host disease (GVHD) requires careful clinical monitoring, with the determination typically made when patients ...